LIV

Emles at Home ETF (LIV)

Emles at Home ETF

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:LIV

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/09/17	06:00	PR Newswire (US)	Emles Advisors Announces Closure of Six Funds	AMEX:LIV	Emles at Home ETF
2007/12/14	00:15	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:LIV	Emles at Home ETF
2007/11/27	23:17	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:LIV	Emles at Home ETF
2007/11/20	02:52	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Quarterly Report (10-Q)	AMEX:LIV	Emles at Home ETF
2007/11/16	04:16	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)	AMEX:LIV	Emles at Home ETF
2007/11/13	20:06	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc (Other)	AMEX:LIV	Emles at Home ETF
2007/11/09	00:06	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Current report filing	AMEX:LIV	Emles at Home ETF
2007/10/03	22:54	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:LIV	Emles at Home ETF
2007/10/03	22:54	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:LIV	Emles at Home ETF
2007/10/01	23:00	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc (Other) (8-K)	AMEX:LIV	Emles at Home ETF
2007/09/28	23:00	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc (Other) (8-K)	AMEX:LIV	Emles at Home ETF
2007/09/22	05:43	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc (Other) (8-K)	AMEX:LIV	Emles at Home ETF
2007/09/20	23:00	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc (Other) (8-K)	AMEX:LIV	Emles at Home ETF
2007/09/18	22:10	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:LIV	Emles at Home ETF
2006/06/15	23:09	Business Wire	Samaritan to Initiate Phase III Clinical Trial in Europe to Accelerate Development Timeline of Its HIV Oral Entry Inhibitor SP0	AMEX:LIV	Emles at Home ETF
2006/05/30	21:59	Business Wire	Samaritan Reports Positive Preliminary Results with ''Oral'' HIV Entry Inhibitor in Phase II 10-Day HIV Monotherapy Trial	AMEX:LIV	Emles at Home ETF
2006/05/23	22:22	Business Wire	Samaritan Files Provisional Patent to Support Promising New Type of Anti-cholesterol Drug SP-1000 and Cover Additional Claims;	AMEX:LIV	Emles at Home ETF
2006/05/02	22:15	Business Wire	Samaritan Starts Enrolling for Its PII Stage 2 (28 Day Monotherapy) Study of ''Oral'' Entry Inhibitor SP-01A	AMEX:LIV	Emles at Home ETF
2006/04/25	21:00	Business Wire	SIS Foundation Driven to Drive Bio Future Bus So Kids Can Speed up Science Innovation; Only 17% of US Students Graduate with Sc	AMEX:LIV	Emles at Home ETF
2006/04/14	02:13	Business Wire	Bio 2006 Analysts Predict Small-Cap Biotechs to Outperform Large-Caps This Year	AMEX:LIV	Emles at Home ETF
2006/04/06	21:30	Business Wire	LIV to Host Annual Shareholders Meeting	AMEX:LIV	Emles at Home ETF
2006/04/04	22:15	Business Wire	Samaritan's Marketing Authorization Application For Amphocil Approved in Greece	AMEX:LIV	Emles at Home ETF
2006/03/30	23:15	Business Wire	Samaritan to Present Its Drugs and Diagnostics for Partnering at BIO 2006 Annual International Conference	AMEX:LIV	Emles at Home ETF
2006/03/28	23:27	Business Wire	New Preclinical Data Shows Samaritan's Cardiovascular Drug Reduces Cholesterol; Cardiovascular Disease is a $15B Market Worldwi	AMEX:LIV	Emles at Home ETF
2006/03/23	23:30	Business Wire	Samaritan is the Little Biotech That Could Be Remembered for Alzheimer's	AMEX:LIV	Emles at Home ETF
2006/03/22	13:01	Business Wire	CORRECTING and REPLACING Samaritan's Adult Stem Cell Drug Displays Money-Making Signs	AMEX:LIV	Emles at Home ETF
2006/03/22	00:29	Business Wire	Samaritan's Adult Stem Cell Drug Displays Money-Making Signs	AMEX:LIV	Emles at Home ETF
2006/03/09	22:00	Business Wire	UPDATE: Samaritan Kicks Off Follow-On HIV Study	AMEX:LIV	Emles at Home ETF
2006/03/01	22:00	Business Wire	Distinguished Cancer Drug Developer Joins Samaritan Scientific Advisory Board	AMEX:LIV	Emles at Home ETF
2006/02/28	22:00	Business Wire	Samaritan's Alzheimer's Drug Registered as CAPROSPINOL; SP-233 (Caprospinol) is Believed to Exhibit Neuroprotective Properties	AMEX:LIV	Emles at Home ETF